secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0001193125-24-102914
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Edward T. Anderson resigns from Lyra board; Snyderman appointed to Audit Committee
--------------------------------------------------------------------------------

- Edward T. Anderson resigned from Lyra's Board, Audit Committee, and Compensation Committee effective April 15, 2024.
- Nancy L. Snyderman was appointed to the Audit Committee on April 15, 2024, filling the vacancy.
- Anderson had been a Board member since 2019 and an investor since 2006; no reason for departure given.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524102914/0001193125-24-102914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524102914/d825056d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-102914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer